March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Learn about violence against women – what it looks like, its link to HIV, danger signs of abuse, leaving a violent relationship, and more.
Learn about HPV – what it is, important vaccines and pap tests, and the genital warts, cervical cancer, and anal cancer it can cause.